Hepatology

A recent study demonstrates hepatocellular carcinoma screening in patients with liver disease and cirrhosis to be associated with improved early-stage tumour detection and survival, persisting after lead-time and length-time bias adjustment.

A new research from the University of Hong Kong has identified bone mineral density as a potentially novel risk factor and early predictor for cirrhosis development. Read more.

Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…

Methotrexate (MTX), an antimetabolite, has a multifarious mechanism of action that most notably includes folate antagonism, effects on…

Anil Dhawan – Professor of Paediatric Hepatology, King’s College London, UK. I started in paediatric hepatology in 1992, when I got a…

Exploring strategies to optimise outcomes for those with HAAA, and assessing both safety and efficacy of HSCT was the goal of an emerging piece of research.

According to research, dietary acid load is significantly associated with cirrhosis-related mortality, and there is further need of investigating underlying mechanisms, as well as establishing optimal DAL levels in patients with cirrhosis.